Carboplatin Injection Market
1 Study Coverage
1.1 Carboplatin Injection Product Introduction
1.2 Market by Type
1.2.1 Global Carboplatin Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 10ml:50mg
1.2.3 10ml:100mg
1.2.4 Other
1.3 Market by Application
1.3.1 Global Carboplatin Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 SCLC
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Carboplatin Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Carboplatin Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Carboplatin Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Carboplatin Injection Sales by Region
2.4.1 Global Carboplatin Injection Sales by Region (2017-2022)
2.4.2 Global Sales Carboplatin Injection by Region (2023-2028)
2.5 Global Carboplatin Injection Revenue by Region
2.5.1 Global Carboplatin Injection Revenue by Region (2017-2022)
2.5.2 Global Carboplatin Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Carboplatin Injection Sales by Manufacturers
3.1.1 Global Top Carboplatin Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Carboplatin Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Carboplatin Injection in 2021
3.2 Global Carboplatin Injection Revenue by Manufacturers
3.2.1 Global Carboplatin Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Carboplatin Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Carboplatin Injection Revenue in 2021
3.3 Global Carboplatin Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Carboplatin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Carboplatin Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Carboplatin Injection Sales by Type
4.1.1 Global Carboplatin Injection Historical Sales by Type (2017-2022)
4.1.2 Global Carboplatin Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Carboplatin Injection Sales Market Share by Type (2017-2028)
4.2 Global Carboplatin Injection Revenue by Type
4.2.1 Global Carboplatin Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Carboplatin Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Carboplatin Injection Revenue Market Share by Type (2017-2028)
4.3 Global Carboplatin Injection Price by Type
4.3.1 Global Carboplatin Injection Price by Type (2017-2022)
4.3.2 Global Carboplatin Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Carboplatin Injection Sales by Application
5.1.1 Global Carboplatin Injection Historical Sales by Application (2017-2022)
5.1.2 Global Carboplatin Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Carboplatin Injection Sales Market Share by Application (2017-2028)
5.2 Global Carboplatin Injection Revenue by Application
5.2.1 Global Carboplatin Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Carboplatin Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Carboplatin Injection Revenue Market Share by Application (2017-2028)
5.3 Global Carboplatin Injection Price by Application
5.3.1 Global Carboplatin Injection Price by Application (2017-2022)
5.3.2 Global Carboplatin Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Carboplatin Injection Market Size by Type
6.1.1 North America Carboplatin Injection Sales by Type (2017-2028)
6.1.2 North America Carboplatin Injection Revenue by Type (2017-2028)
6.2 North America Carboplatin Injection Market Size by Application
6.2.1 North America Carboplatin Injection Sales by Application (2017-2028)
6.2.2 North America Carboplatin Injection Revenue by Application (2017-2028)
6.3 North America Carboplatin Injection Market Size by Country
6.3.1 North America Carboplatin Injection Sales by Country (2017-2028)
6.3.2 North America Carboplatin Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Carboplatin Injection Market Size by Type
7.1.1 Europe Carboplatin Injection Sales by Type (2017-2028)
7.1.2 Europe Carboplatin Injection Revenue by Type (2017-2028)
7.2 Europe Carboplatin Injection Market Size by Application
7.2.1 Europe Carboplatin Injection Sales by Application (2017-2028)
7.2.2 Europe Carboplatin Injection Revenue by Application (2017-2028)
7.3 Europe Carboplatin Injection Market Size by Country
7.3.1 Europe Carboplatin Injection Sales by Country (2017-2028)
7.3.2 Europe Carboplatin Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Carboplatin Injection Market Size by Type
8.1.1 Asia Pacific Carboplatin Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Carboplatin Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Carboplatin Injection Market Size by Application
8.2.1 Asia Pacific Carboplatin Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Carboplatin Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Carboplatin Injection Market Size by Region
8.3.1 Asia Pacific Carboplatin Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Carboplatin Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Carboplatin Injection Market Size by Type
9.1.1 Latin America Carboplatin Injection Sales by Type (2017-2028)
9.1.2 Latin America Carboplatin Injection Revenue by Type (2017-2028)
9.2 Latin America Carboplatin Injection Market Size by Application
9.2.1 Latin America Carboplatin Injection Sales by Application (2017-2028)
9.2.2 Latin America Carboplatin Injection Revenue by Application (2017-2028)
9.3 Latin America Carboplatin Injection Market Size by Country
9.3.1 Latin America Carboplatin Injection Sales by Country (2017-2028)
9.3.2 Latin America Carboplatin Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Carboplatin Injection Market Size by Type
10.1.1 Middle East and Africa Carboplatin Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Carboplatin Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Carboplatin Injection Market Size by Application
10.2.1 Middle East and Africa Carboplatin Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Carboplatin Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Carboplatin Injection Market Size by Country
10.3.1 Middle East and Africa Carboplatin Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Carboplatin Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Hospira(Pfizer)
11.1.1 Hospira(Pfizer) Corporation Information
11.1.2 Hospira(Pfizer) Overview
11.1.3 Hospira(Pfizer) Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Hospira(Pfizer) Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hospira(Pfizer) Recent Developments
11.2 Bristol-Myers Squibb SA
11.2.1 Bristol-Myers Squibb SA Corporation Information
11.2.2 Bristol-Myers Squibb SA Overview
11.2.3 Bristol-Myers Squibb SA Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bristol-Myers Squibb SA Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bristol-Myers Squibb SA Recent Developments
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Overview
11.3.3 Teva Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Teva Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Overview
11.4.3 Mylan Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylan Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Taj Pharmaceuticals
11.5.1 Taj Pharmaceuticals Corporation Information
11.5.2 Taj Pharmaceuticals Overview
11.5.3 Taj Pharmaceuticals Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Taj Pharmaceuticals Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Taj Pharmaceuticals Recent Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Corporation Information
11.6.2 Fresenius Kabi Overview
11.6.3 Fresenius Kabi Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Fresenius Kabi Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Fresenius Kabi Recent Developments
11.7 Qilu Pharmaceutical
11.7.1 Qilu Pharmaceutical Corporation Information
11.7.2 Qilu Pharmaceutical Overview
11.7.3 Qilu Pharmaceutical Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Qilu Pharmaceutical Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Qilu Pharmaceutical Recent Developments
11.8 Cisen Pharmaceutical
11.8.1 Cisen Pharmaceutical Corporation Information
11.8.2 Cisen Pharmaceutical Overview
11.8.3 Cisen Pharmaceutical Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Cisen Pharmaceutical Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cisen Pharmaceutical Recent Developments
11.9 Yunnan Phytopharmaceutical
11.9.1 Yunnan Phytopharmaceutical Corporation Information
11.9.2 Yunnan Phytopharmaceutical Overview
11.9.3 Yunnan Phytopharmaceutical Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Yunnan Phytopharmaceutical Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Yunnan Phytopharmaceutical Recent Developments
11.10 Hisun
11.10.1 Hisun Corporation Information
11.10.2 Hisun Overview
11.10.3 Hisun Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hisun Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hisun Recent Developments
11.11 Jiangsu Lianhuan Pharmaceutical
11.11.1 Jiangsu Lianhuan Pharmaceutical Corporation Information
11.11.2 Jiangsu Lianhuan Pharmaceutical Overview
11.11.3 Jiangsu Lianhuan Pharmaceutical Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Jiangsu Lianhuan Pharmaceutical Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jiangsu Lianhuan Pharmaceutical Recent Developments
11.12 Yangzijiang Group
11.12.1 Yangzijiang Group Corporation Information
11.12.2 Yangzijiang Group Overview
11.12.3 Yangzijiang Group Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Yangzijiang Group Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Yangzijiang Group Recent Developments
11.13 Shandong Ruiying
11.13.1 Shandong Ruiying Corporation Information
11.13.2 Shandong Ruiying Overview
11.13.3 Shandong Ruiying Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Shandong Ruiying Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shandong Ruiying Recent Developments
11.14 Shanghai Acebright Pharmaceuticals
11.14.1 Shanghai Acebright Pharmaceuticals Corporation Information
11.14.2 Shanghai Acebright Pharmaceuticals Overview
11.14.3 Shanghai Acebright Pharmaceuticals Carboplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Shanghai Acebright Pharmaceuticals Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Shanghai Acebright Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Carboplatin Injection Industry Chain Analysis
12.2 Carboplatin Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Carboplatin Injection Production Mode & Process
12.4 Carboplatin Injection Sales and Marketing
12.4.1 Carboplatin Injection Sales Channels
12.4.2 Carboplatin Injection Distributors
12.5 Carboplatin Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Carboplatin Injection Industry Trends
13.2 Carboplatin Injection Market Drivers
13.3 Carboplatin Injection Market Challenges
13.4 Carboplatin Injection Market Restraints
14 Key Findings in The Global Carboplatin Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Carboplatin Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 10ml:50mg
Table 3. Major Manufacturers of 10ml:100mg
Table 4. Major Manufacturers of Other
Table 5. Global Carboplatin Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Carboplatin Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Carboplatin Injection Sales by Region (2017-2022) & (K Units)
Table 8. Global Carboplatin Injection Sales Market Share by Region (2017-2022)
Table 9. Global Carboplatin Injection Sales by Region (2023-2028) & (K Units)
Table 10. Global Carboplatin Injection Sales Market Share by Region (2023-2028)
Table 11. Global Carboplatin Injection Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Carboplatin Injection Revenue Market Share by Region (2017-2022)
Table 13. Global Carboplatin Injection Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Carboplatin Injection Revenue Market Share by Region (2023-2028)
Table 15. Global Carboplatin Injection Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Carboplatin Injection Sales Share by Manufacturers (2017-2022)
Table 17. Global Carboplatin Injection Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Carboplatin Injection Revenue Share by Manufacturers (2017-2022)
Table 19. Carboplatin Injection Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Carboplatin Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Carboplatin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carboplatin Injection as of 2021)
Table 22. Carboplatin Injection Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Carboplatin Injection Product Offered
Table 24. Date of Manufacturers Enter into Carboplatin Injection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Carboplatin Injection Sales by Type (2017-2022) & (K Units)
Table 27. Global Carboplatin Injection Sales by Type (2023-2028) & (K Units)
Table 28. Global Carboplatin Injection Sales Share by Type (2017-2022)
Table 29. Global Carboplatin Injection Sales Share by Type (2023-2028)
Table 30. Global Carboplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Carboplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Carboplatin Injection Revenue Share by Type (2017-2022)
Table 33. Global Carboplatin Injection Revenue Share by Type (2023-2028)
Table 34. Carboplatin Injection Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Carboplatin Injection Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Carboplatin Injection Sales by Application (2017-2022) & (K Units)
Table 37. Global Carboplatin Injection Sales by Application (2023-2028) & (K Units)
Table 38. Global Carboplatin Injection Sales Share by Application (2017-2022)
Table 39. Global Carboplatin Injection Sales Share by Application (2023-2028)
Table 40. Global Carboplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Carboplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Carboplatin Injection Revenue Share by Application (2017-2022)
Table 43. Global Carboplatin Injection Revenue Share by Application (2023-2028)
Table 44. Carboplatin Injection Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Carboplatin Injection Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Carboplatin Injection Sales by Type (2017-2022) & (K Units)
Table 47. North America Carboplatin Injection Sales by Type (2023-2028) & (K Units)
Table 48. North America Carboplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Carboplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Carboplatin Injection Sales by Application (2017-2022) & (K Units)
Table 51. North America Carboplatin Injection Sales by Application (2023-2028) & (K Units)
Table 52. North America Carboplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Carboplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Carboplatin Injection Sales by Country (2017-2022) & (K Units)
Table 55. North America Carboplatin Injection Sales by Country (2023-2028) & (K Units)
Table 56. North America Carboplatin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Carboplatin Injection Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Carboplatin Injection Sales by Type (2017-2022) & (K Units)
Table 59. Europe Carboplatin Injection Sales by Type (2023-2028) & (K Units)
Table 60. Europe Carboplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Carboplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Carboplatin Injection Sales by Application (2017-2022) & (K Units)
Table 63. Europe Carboplatin Injection Sales by Application (2023-2028) & (K Units)
Table 64. Europe Carboplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Carboplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Carboplatin Injection Sales by Country (2017-2022) & (K Units)
Table 67. Europe Carboplatin Injection Sales by Country (2023-2028) & (K Units)
Table 68. Europe Carboplatin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Carboplatin Injection Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Carboplatin Injection Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Carboplatin Injection Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Carboplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Carboplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Carboplatin Injection Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Carboplatin Injection Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Carboplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Carboplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Carboplatin Injection Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Carboplatin Injection Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Carboplatin Injection Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Carboplatin Injection Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Carboplatin Injection Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Carboplatin Injection Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Carboplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Carboplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Carboplatin Injection Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Carboplatin Injection Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Carboplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Carboplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Carboplatin Injection Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Carboplatin Injection Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Carboplatin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Carboplatin Injection Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Carboplatin Injection Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Carboplatin Injection Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Carboplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Carboplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Carboplatin Injection Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Carboplatin Injection Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Carboplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Carboplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Carboplatin Injection Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Carboplatin Injection Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Carboplatin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Carboplatin Injection Revenue by Country (2023-2028) & (US$ Million)
Table 106. Hospira(Pfizer) Corporation Information
Table 107. Hospira(Pfizer) Description and Major Businesses
Table 108. Hospira(Pfizer) Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Hospira(Pfizer) Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Hospira(Pfizer) Recent Developments
Table 111. Bristol-Myers Squibb SA Corporation Information
Table 112. Bristol-Myers Squibb SA Description and Major Businesses
Table 113. Bristol-Myers Squibb SA Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Bristol-Myers Squibb SA Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Bristol-Myers Squibb SA Recent Developments
Table 116. Teva Corporation Information
Table 117. Teva Description and Major Businesses
Table 118. Teva Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Teva Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Teva Recent Developments
Table 121. Mylan Corporation Information
Table 122. Mylan Description and Major Businesses
Table 123. Mylan Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Mylan Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Mylan Recent Developments
Table 126. Taj Pharmaceuticals Corporation Information
Table 127. Taj Pharmaceuticals Description and Major Businesses
Table 128. Taj Pharmaceuticals Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Taj Pharmaceuticals Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Taj Pharmaceuticals Recent Developments
Table 131. Fresenius Kabi Corporation Information
Table 132. Fresenius Kabi Description and Major Businesses
Table 133. Fresenius Kabi Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Fresenius Kabi Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Fresenius Kabi Recent Developments
Table 136. Qilu Pharmaceutical Corporation Information
Table 137. Qilu Pharmaceutical Description and Major Businesses
Table 138. Qilu Pharmaceutical Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Qilu Pharmaceutical Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Qilu Pharmaceutical Recent Developments
Table 141. Cisen Pharmaceutical Corporation Information
Table 142. Cisen Pharmaceutical Description and Major Businesses
Table 143. Cisen Pharmaceutical Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Cisen Pharmaceutical Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Cisen Pharmaceutical Recent Developments
Table 146. Yunnan Phytopharmaceutical Corporation Information
Table 147. Yunnan Phytopharmaceutical Description and Major Businesses
Table 148. Yunnan Phytopharmaceutical Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Yunnan Phytopharmaceutical Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Yunnan Phytopharmaceutical Recent Developments
Table 151. Hisun Corporation Information
Table 152. Hisun Description and Major Businesses
Table 153. Hisun Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Hisun Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Hisun Recent Developments
Table 156. Jiangsu Lianhuan Pharmaceutical Corporation Information
Table 157. Jiangsu Lianhuan Pharmaceutical Description and Major Businesses
Table 158. Jiangsu Lianhuan Pharmaceutical Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. Jiangsu Lianhuan Pharmaceutical Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Jiangsu Lianhuan Pharmaceutical Recent Developments
Table 161. Yangzijiang Group Corporation Information
Table 162. Yangzijiang Group Description and Major Businesses
Table 163. Yangzijiang Group Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 164. Yangzijiang Group Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Yangzijiang Group Recent Developments
Table 166. Shandong Ruiying Corporation Information
Table 167. Shandong Ruiying Description and Major Businesses
Table 168. Shandong Ruiying Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 169. Shandong Ruiying Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Shandong Ruiying Recent Developments
Table 171. Shanghai Acebright Pharmaceuticals Corporation Information
Table 172. Shanghai Acebright Pharmaceuticals Description and Major Businesses
Table 173. Shanghai Acebright Pharmaceuticals Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 174. Shanghai Acebright Pharmaceuticals Carboplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Shanghai Acebright Pharmaceuticals Recent Developments
Table 176. Key Raw Materials Lists
Table 177. Raw Materials Key Suppliers Lists
Table 178. Carboplatin Injection Distributors List
Table 179. Carboplatin Injection Customers List
Table 180. Carboplatin Injection Market Trends
Table 181. Carboplatin Injection Market Drivers
Table 182. Carboplatin Injection Market Challenges
Table 183. Carboplatin Injection Market Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Carboplatin Injection Product Picture
Figure 3. Global Carboplatin Injection Market Share by Type in 2021 & 2028
Figure 3. 10ml:50mg Product Picture
Figure 4. 10ml:100mg Product Picture
Figure 5. Other Product Picture
Figure 6. Global Carboplatin Injection Market Share by Application in 2021 & 2028
Figure 7. Ovarian Cancer
Figure 8. Breast Cancer
Figure 9. SCLC
Figure 10. Other
Figure 11. Carboplatin Injection Report Years Considered
Figure 12. Global Carboplatin Injection Sales 2017-2028 (K Units)
Figure 13. Global Carboplatin Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Carboplatin Injection Revenue 2017-2028 (US$ Million)
Figure 15. Global Carboplatin Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Carboplatin Injection Sales Market Share by Region (2017-2022)
Figure 17. Global Carboplatin Injection Sales Market Share by Region (2023-2028)
Figure 18. North America Carboplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 19. North America Carboplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Carboplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Carboplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Carboplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Carboplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Carboplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Carboplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Carboplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Carboplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Carboplatin Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Carboplatin Injection in the World: Market Share by Carboplatin Injection Revenue in 2021
Figure 30. Global Carboplatin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Carboplatin Injection Sales Market Share by Type (2017-2028)
Figure 32. Global Carboplatin Injection Revenue Market Share by Type (2017-2028)
Figure 33. Global Carboplatin Injection Sales Market Share by Application (2017-2028)
Figure 34. Global Carboplatin Injection Revenue Market Share by Application (2017-2028)
Figure 35. North America Carboplatin Injection Sales Market Share by Type (2017-2028)
Figure 36. North America Carboplatin Injection Revenue Market Share by Type (2017-2028)
Figure 37. North America Carboplatin Injection Sales Market Share by Application (2017-2028)
Figure 38. North America Carboplatin Injection Revenue Market Share by Application (2017-2028)
Figure 39. North America Carboplatin Injection Sales Share by Country (2017-2028)
Figure 40. North America Carboplatin Injection Revenue Share by Country (2017-2028)
Figure 41. United States Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Carboplatin Injection Sales Market Share by Type (2017-2028)
Figure 44. Europe Carboplatin Injection Revenue Market Share by Type (2017-2028)
Figure 45. Europe Carboplatin Injection Sales Market Share by Application (2017-2028)
Figure 46. Europe Carboplatin Injection Revenue Market Share by Application (2017-2028)
Figure 47. Europe Carboplatin Injection Sales Share by Country (2017-2028)
Figure 48. Europe Carboplatin Injection Revenue Share by Country (2017-2028)
Figure 49. Germany Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 50. France Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Carboplatin Injection Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Carboplatin Injection Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Carboplatin Injection Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Carboplatin Injection Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Carboplatin Injection Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Carboplatin Injection Revenue Share by Region (2017-2028)
Figure 60. China Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 63. India Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Carboplatin Injection Sales Market Share by Type (2017-2028)
Figure 70. Latin America Carboplatin Injection Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Carboplatin Injection Sales Market Share by Application (2017-2028)
Figure 72. Latin America Carboplatin Injection Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Carboplatin Injection Sales Share by Country (2017-2028)
Figure 74. Latin America Carboplatin Injection Revenue Share by Country (2017-2028)
Figure 75. Mexico Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Carboplatin Injection Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Carboplatin Injection Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Carboplatin Injection Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Carboplatin Injection Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Carboplatin Injection Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Carboplatin Injection Revenue Share by Country (2017-2028)
Figure 84. Turkey Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Carboplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 87. Carboplatin Injection Value Chain
Figure 88. Carboplatin Injection Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Industry Market Size
